The risk factors for herpes zoster in bortezomib treatment in patients with multiple myeloma

BACKGROUND: Bortezomib has significant activity in treating multiple myeloma (MM). The risk of herpes zoster (HZ) has been reported to increase significantly with bortezomib treatment, but the predisposing factors for HZ are not clear. This study is a retrospective analysis of the relevant risk fact...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Yang-Seon, Chung, Joo-Seop, Song, Moo-Kon, Shin, Ho-Jin, Seol, Young-Mi, Choi, Young-Jin, Cho, Goon-Jae, Lee, Gyeong-Won, Moon, Joon-Ho, Hwang, In-Hye, Ahn, Kang-Hee, Lee, Hee-Sun, Shin, Kyung-Hwa, Hwang, Jong-Min
Formato: Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2983043/
https://www.ncbi.nlm.nih.gov/pubmed/21120208
http://dx.doi.org/10.5045/kjh.2010.45.3.188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2983043/
https://www.ncbi.nlm.nih.gov/pubmed/21120208
http://dx.doi.org/10.5045/kjh.2010.45.3.188

Ejemplares similares